PHIO
Phio Pharmaceuticals Corp.
1.00
11 x 1.01
2 x 1.29
bid
ask
-
0.02
2.44%
7 @ 04:00 PM
1.00 -0.00 (0.02%)
Ytd-4.76%
1y-59.68%
1.00
day range
1.05
0.81
52 week range
4.19
Open1.02Prev Close1.02Low1.00High1.05Mkt Cap11.62M
Vol146.58KAvg Vol158.05KEPS-1.38P/EN/AForward P/E0.07
Beta1.47Short Ratio0.50Inst. Own3.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.10200-d Avg1.351yr Est36.00
Income Statement
Operating Expenses4.17M
Research and Development Expense2.79M
Selling, General and Administrative Expense1.37M
Operating Income-4.17M
Net Income-4.00M
Net Income Common Stock-4.00M
Net Income Common Stock (USD)-4.00M
Consolidated Income-4.00M
Earnings per Basic Share-0.34
Earnings per Basic Share (USD)-0.34
Earnings per Diluted Share-0.34
Earning Before Interest & Taxes (EBIT)-4.00M
Earning Before Interest & Taxes (USD)-4.00M
Weighted Average Shares11.62M
Weighted Average Shares Diluted11.62M
Balance Sheet
Cash and Equivalents17.03M
Cash and Equivalents (USD)17.03M
Current Assets17.40M
Property, Plant & Equipment Net10.00K
Total Assets17.41M
Current Liabilities950.00K
Total Liabilities950.00K
Accumulated Retained Earnings (Deficit)-159.06M
Shareholders Equity16.46M
Shareholders Equity (USD)16.46M
Assets Non-Current10.00K
Trade and Non-Trade Payables260.00K
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow / Change in Cash & Cash Equivalents-4.00M
Net Cash Flow - Business Acquisitions and Disposals3.00K
Net Cash Flow from Investing3.00K
Net Cash Flow from Operations-4.00M
Share Based Compensation318.00K